Interindividual responses to different exercise stimuli among insulin-resistant women.
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
high-intensity interval training (HIT) | decrease | fasting glucose | insulin-resistant adult women | -5.7 mg/dL | reduced | #1 |
resistance training (RT) | decrease | fasting glucose | insulin-resistant adult women | -5.1 mg/dL | reduced | #2 |
high-intensity interval training (HIT) | decrease | fasting insulin | insulin-resistant adult women | -0.6 μIU/mL | reduced | #3 |
resistance training (RT) | decrease | fasting insulin | insulin-resistant adult women | -0.6 μIU/mL | reduced | #4 |
high-intensity interval training (HIT) | decrease | HOMA-IR | insulin-resistant adult women | -0.3 | reduced | #5 |
resistance training (RT) | decrease | HOMA-IR | insulin-resistant adult women | -0.4 | reduced | #6 |
high-intensity interval training (HIT) | increase | cardiovascular parameters | insulin-resistant adult women | - | improved | #7 |
resistance training (RT) | increase | cardiovascular parameters | insulin-resistant adult women | - | improved | #8 |
concurrent training (CT) | increase | cardiovascular parameters | insulin-resistant adult women | - | improved | #9 |
high-intensity interval training (HIT) | increase | performance parameters | insulin-resistant adult women | - | improved | #10 |
resistance training (RT) | increase | performance parameters | insulin-resistant adult women | - | improved | #11 |
concurrent training (CT) | increase | performance parameters | insulin-resistant adult women | - | improved | #12 |
resistance training (RT) | no change | 20 cardiometabolic and performance outcomes | insulin-resistant adult women | - | had the lowest number of total non-responses | #13 |
concurrent training (CT) | no change | 20 cardiometabolic and performance outcomes | insulin-resistant adult women | - | had the second lowest number of total non-responses | #14 |
high-intensity interval training (HIT) | no change | 20 cardiometabolic and performance outcomes | insulin-resistant adult women | - | had the third lowest number of total non-responses | #15 |
control group (CG) | no change | almost all variables | insulin-resistant adult women | - | were classified as non-responders | #16 |
resistance training (RT) | decrease | 20 outcomes of health and performance | insulin-resistant adult women | - | has an important ability to reduce the prevalence of non-response | #17 |
We aimed to investigate which among 20 cardiometabolic and performance outcomes do and do not respond to high-intensity interval training (HIT), resistance training (RT), or concurrent training (CT) in insulin-resistant adult women. A secondary aim was to report the training-induced changes and the prevalence of non-responders. Forty-five insulin-resistant adult women were randomly assigned to one of the following 4 groups: HIT (39.2 ± 9.5 years [y]; body mass index [BMI], 29.3 ± 3.3; n = 14), RT (33.9 ± 9.3 y; BMI, 29.4 ± 5.5; n = 8), CT (43.3 ± 8.1 y; BMI, 29.1 ± 2.9; n = 10), and a control group (CG, 40.1 ± 11.4 y; BMI, 28.3 ± 3.5; n = 13). Nine body composition, 3 cardiovascular, 3 metabolic, and 5 performance outcomes were assessed at baseline and after 12 weeks of intervention. Considering all outcomes, the lowest number of total non-responses for one or more variables was found in the RT group, followed by the CT and HIT groups. Individuals in the CG group were classified as non-responders for almost all the variables. Moreover, there were several significant changes in body composition and metabolic parameters, including fasting glucose (HIT: -5.7, RT -5.1 mg/d), fasting insulin (HIT: -0.6, RT -0.6 μIU/mL), and HOMA-IR (HIT: -0.3, RT -0.4), in addition to improvements in cardiovascular and performance parameters. Also, there were significant differences among groups in the prevalence of non-responders for the variables where a non-response was detected. Overall, the study suggests that independent of the mode of training including volume and frequency, RT has an important ability to reduce the prevalence of non-response to improve the 20 outcomes of health and performance in insulin-resistant adult women.